Haunted by the cystic fibrosis patients he could not help, one Iowa doctor commits his life to understanding what is broken deep inside their cells.

St. Luke’s University Health Network has been designated as a Care Center within the Pulmonary Fibrosis Foundation’s nationally recognized Care Center Network, expanding access to specialized care ...

DLCO declined earliest, falling measurably about 10 years before the defined onset. By five years before onset, DLCO had ...

St. Luke’s University Health Network has been designated as a Care Center within the Pulmonary Fibrosis Foundation’s (PFF) nationally recognized Care Center Network, expanding access to specialized ca ...

In idiopathic pulmonary fibrosis (IPF), the trajectory of declining lung function and clinical worsening was less drastic with the use of inhaled treprostinil (Tyvaso), the placeb ...

Two pivotal Phase 3 trials of Haduvio are expected to launch this year and, if positive, may support applications seeking its approval.

Pigeon droppings may seem harmless, but repeated exposure can trigger serious lung conditions like hypersensitivity pneumonitis that may lead to lung fibrosis.

Conference call and webcast to be held at 4:30 p.m. ETNEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics ...

The company announced its decision following a meeting with the U.S. Food and Drug Administration.

The Company will conduct two Phase 3 clinical trials of nalbuphine ER for the treatment of patients with IPF-related chronic cough First pivotal trial is on track to initiate in the second quarter of ...

The Company will conduct two Phase 3 clinical trials of nalbuphine ER for the treatment of patients with IPF-related chronic coughFirst pivotal ...

Savara Inc. (the "Company") (Nasdaq: SVRA), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, ...